1.

Why is the introduction of genetically engineered lymphocytes into an ADA deficiency patient not a permanent cure? Suggest a possible permanent cure.

Answer»

Introduction of genetically engineered lymphocytes into a ADA deficiency patient is not a permanent cure because these cells are not immortal and the patient requires periodic infusion of such genetically engineered lymphocytes. A possible permanent cure can be isolating the gene producing Adenosine Deaminase (ADA) from bone marrow cells and introducing it into cells at early embryonic stages.



Discussion

No Comment Found

Related InterviewSolutions